Literature DB >> 15140194

Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells.

Harsimran S Saini1, Karen M Gorse, Linda M Boxer, Carmen Sato-Bigbee.   

Abstract

Our previous results suggested that the transcription factor CREB mediates the actions of neuroligands and growth factor signals that coupled to different signaling pathways may play different roles along oligodendrocyte (OLG) development. We showed before that CREB phosphorylation in OLG progenitors is up-regulated by neurotrophin-3 (NT-3); and moreover CREB is required for NT-3 to stimulate the proliferation of these cells. We now show that treatment of OLG progenitors with NT-3 is also accompanied by an increase in the levels of the anti-apoptotic protein Bcl-2. Interestingly, the presence of a putative CREB binding site (CRE) in the Bcl-2 gene raised the possibility that CREB could also be involved in regulating Bcl-2 expression in the OLGs. Supporting this hypothesis, the NT-3 dependent increase in Bcl-2 levels is abolished by inhibition of CREB expression. In addition, transient transfection experiments using various regions of the Bcl-2 promoter and mutation of the CRE site indicate a direct role of CREB in regulating Bcl-2 gene activity in response to NT-3. Furthermore, protein-DNA binding assays show that the CREB protein from freshly isolated OLGs indeed binds to the Bcl-2 promoter CRE. Together with our previous results, these observations suggest that CREB may play an important role in linking proliferation and survival pathways in the OLG progenitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140194     DOI: 10.1111/j.1471-4159.2004.02365.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  A novel nuclear signaling pathway for thromboxane A2 receptors in oligodendrocytes: evidence for signaling compartmentalization during differentiation.

Authors:  Fozia Mir; Guy C Le Breton
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

2.  Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.

Authors:  Thomas K Creson; Peixiong Yuan; Husseini K Manji; Guang Chen
Journal:  J Mol Neurosci       Date:  2008-08-03       Impact factor: 3.444

Review 3.  G-protein-coupled receptors in adult neurogenesis.

Authors:  Van A Doze; Dianne M Perez
Journal:  Pharmacol Rev       Date:  2012-05-18       Impact factor: 25.468

4.  Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice.

Authors:  Nobukazu Miyamoto; Takakuni Maki; Loc-Duyen D Pham; Kazuhide Hayakawa; Ji Hae Seo; Emiri T Mandeville; Joseph B Mandeville; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  Stroke       Date:  2013-09-26       Impact factor: 7.914

Review 5.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

6.  Electro-acupuncture promotes survival, differentiation of the bone marrow mesenchymal stem cells as well as functional recovery in the spinal cord-transected rats.

Authors:  Ying Ding; Qing Yan; Jing-Wen Ruan; Yan-Qing Zhang; Wen-Jie Li; Yu-Jiao Zhang; Yan Li; Hongxin Dong; Yuan-Shan Zeng
Journal:  BMC Neurosci       Date:  2009-04-20       Impact factor: 3.288

7.  CREB, a possible upstream regulator of Bcl-2 in trichosanthin-induced HeLa cell apoptosis.

Authors:  Ping Wang; Jin Xu; Cheng Zhang
Journal:  Mol Biol Rep       Date:  2009-07-21       Impact factor: 2.316

8.  Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes.

Authors:  Rochelle P Coelho; Larra M Yuelling; Babette Fuss; Carmen Sato-Bigbee
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

9.  Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain.

Authors:  Nobukazu Miyamoto; Ryota Tanaka; Hideki Shimura; Terubumi Watanabe; Hideo Mori; Masafumi Onodera; Hideki Mochizuki; Nobutaka Hattori; Takao Urabe
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-14       Impact factor: 6.200

10.  Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

Authors:  N Rajan; R Elliott; O Clewes; A Mackay; J S Reis-Filho; J Burn; J Langtry; M Sieber-Blum; C J Lord; A Ashworth
Journal:  Oncogene       Date:  2011-05-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.